Europe Dermatology OTC Medications Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

No. of Pages: 216
Report Code: BMIRE00025069
Category: Life Sciences
Europe Dermatology OTC Medications Market
Buy Now

The Europe dermatology OTC medications market is expected to grow from US$ 4,068.29 million in 2021 to US$ 5,321.86 million by 2028; it is estimated to grow at a CAGR of 3.9% from 2021 to 2028.

As per European Union, the middle-class population is expected to reach 5.3 billion by 2030, and the population of middle-class people is likely to be at the forefront. With significant changes in consumer behavior and consumption patterns, the middle-class expansion will likely drive regional economic development. With the increase in disposable incomes and better after-care treatment, the general attitude toward skin-related conditions is leading to the mounting adoption of dermatology OTC medications to treat skin conditions. Thus, a surge in the adoption rate of OTC medications, with the increase in disposable income of populations, support the growth of the dermatology OTC medications market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe dermatology OTC medications market. The Europe dermatology OTC medications market is expected to grow at a good CAGR during the forecast period. 

 

Europe Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    
Europe Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    

Europe Dermatology OTC Medications Market Segmentation    

 

The Europe dermatology OTC medications market is segmented into product type, route of administration, indication, distribution channel, and country. Based on product type, the market is segmented into tablets and capsules, gels, creams and ointments, and others. The creams and ointments segment dominated the market in 2020; however, the tablets and capsules segment is expected to be the fastest growing segment during the forecast period. Based on route of administration, the market is segmented into topical and oral. The topical segment dominated the market in 2020; however the oral segment is expected to be a faster growing segment during the forecast period. Based on indication, the market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment dominated the market in 2020, and is expected to be the fastest growing segment during the forecast period. The dermatitis segment is further classified into atopic dermatitis, contact dermatitis, and others. The acne segment is also segmented into non-inflammatory acne and inflammatory acne. The psoriasis segment is segmented into plaque psoriasis, guttate psoriasis, and others. The fungal disease is further segmented into athlete's foot, ringworm, fungal nail infections, and others. Moreover, the warts segment is further segmented into common warts, flat warts, and others. Based on distribution channel, the market is segmented into online distribution and offline distribution. The offline distribution segment dominated the market in 2020; however online distribution segment is expected to be a faster growing segment during the forecast period. The offline distribution is further segmented into retail and hospital pharmacies and super and hypermarkets. Based on country, the market is segmented into the UK, Germany, France, Italy, Spain, and the rest of Europe.        

 

Bausch Health Companies Inc.; Bayer AG; Dr. Reddy's Laboratories; Galderma; GlaxoSmithKline plc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; Perrigo Company plc; and Viatris Inc. are among the leading companies in the Europe dermatology OTC medications market.  

Europe Dermatology OTC Medications Market Strategic Insights

global-market-strategic-framework
Get more information on this report

Europe Dermatology OTC Medications Market Segmentation Analysis

Europe Dermatology OTC Medications Market Report Highlights

Europe Dermatology OTC Medications Report Scope

Report Attribute Details
Market size in 2021 US$ 4,068.29 Million
Market Size by 2028 US$ 5,321.86 Million
CAGR (2021 - 2028) 3.9%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Tablets and Capsules
  • Gels
  • Creams
  • Ointments
By Route of Administration
  • Topical
  • Oral
By Indication
  • Dermatitis
  • Acne
  • Psoriasis
  • Skin Bleaching
  • Fungal Disease
  • Warts
By Distribution Channel
  • Online Distribution
  • Offline Distribution
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Bausch Health Companies Inc.
  • Bayer AG
  • Dr. Reddy's Laboratories
  • Galderma
  • GlaxoSmithKline plc.
  • Johnson and Johnson Services, Inc.
  • LEO Pharma A/S
  • Perrigo Company plc
  • Viatris Inc.
Get more information on this report

Europe Dermatology OTC Medications Market Country and Regional Insights

europe-dermatology-otc-medications-market
Get more information on this report

The List of Companies - Europe Dermatology OTC Medications Market

  1. Bausch Health Companies Inc.
  2. Bayer AG
  3. Dr. Reddy's Laboratories
  4. Galderma
  5. GlaxoSmithKline plc.
  6. Johnson and Johnson Services, Inc.
  7. LEO Pharma A/S   
  8. Perrigo Company plc
  9. Viatris Inc.  
Frequently Asked Questions
How big is the Europe Dermatology OTC Medications Market?

The Europe Dermatology OTC Medications Market is valued at US$ 4,068.29 Million in 2021, it is projected to reach US$ 5,321.86 Million by 2028.

What is the CAGR for Europe Dermatology OTC Medications Market by (2021 - 2028)?

As per our report Europe Dermatology OTC Medications Market, the market size is valued at US$ 4,068.29 Million in 2021, projecting it to reach US$ 5,321.86 Million by 2028. This translates to a CAGR of approximately 3.9% during the forecast period.

What segments are covered in this report?

The Europe Dermatology OTC Medications Market report typically cover these key segments-

  • Product Type (Tablets and Capsules, Gels, Creams, Ointments)
  • Route of Administration (Topical, Oral)
  • Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts)
  • Distribution Channel (Online Distribution, Offline Distribution)

What is the historic period, base year, and forecast period taken for Europe Dermatology OTC Medications Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Dermatology OTC Medications Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Dermatology OTC Medications Market?

    The Europe Dermatology OTC Medications Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bausch Health Companies Inc.
  • Bayer AG
  • Dr. Reddy's Laboratories
  • Galderma
  • GlaxoSmithKline plc.
  • Johnson and Johnson Services, Inc.
  • LEO Pharma A/S
  • Perrigo Company plc
  • Viatris Inc.
  • Who should buy this report?

    The Europe Dermatology OTC Medications Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Dermatology OTC Medications Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now

    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)